TSGA10 and cancer: Thus, TSGA10 emerges as a potential metabolic gatekeeper whose dysregulation could link mitochondrial coupling defects, ROS-driven mutagenesis, and metabolic reprogramming in cancer progression, offering novel therapeutic targets to disrupt tumor energetics.